[New approval: Atezolizumab and bevacizumab for first line of unresecable hepatocellular carcinoma].

[New approval: Atezolizumab and bevacizumab for first line of unresecable hepatocellular carcinoma]. Bull Cancer. 2021 Feb 02;: Authors: Minot-This MS, Edeline J PMID: 33546873 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33546873?dopt=Abstract

Source: Bulletin du Cancer - February 2, 2021 Category: Cancer & Oncology Authors: Minot-This MS, Edeline J Tags: Bull Cancer Source Type: research